Click Here for 5% Off Your First Aladdin Purchase!

retigabine derivative 10g , CAS No.R613161, Activator of K v7.4;Activator of K v7.5

  • Moligand™
Item Number
R613161
Grouped product items
SKUSizeAvailabilityPrice Qty
R613161-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,334.90
R613161-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,000.90
View related series
Kv7.4 Activator Kv7.5 Activator

Basic Description

Synonymscompound 10g
Specifications & PurityMoligand™
GradeMoligand™
Action TypeACTIVATOR
Mechanism of actionActivator of K v7.4;Activator of K v7.5

Associated Targets

KCNQ4 Tclin Potassium voltage-gated channel subfamily KQT member 4 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

KCNQ5 Tclin Potassium voltage-gated channel subfamily KQT member 5 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

KCNQ2 Tclin Potassium voltage-gated channel subfamily KQT member 2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

KCNQ3 Tclin Potassium voltage-gated channel subfamily KQT member 3 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name tert-butyl N-[2-(ethoxycarbonylamino)-5-[(4-fluorophenyl)methyl-prop-2-ynylamino]phenyl]carbamate
INCHI InChI=1S/C24H28FN3O4/c1-6-14-28(16-17-8-10-18(25)11-9-17)19-12-13-20(26-22(29)31-7-2)21(15-19)27-23(30)32-24(3,4)5/h1,8-13,15H,7,14,16H2,2-5H3,(H,26,29)(H,27,30)
InChi Key FWQHRZXEQNUCSY-UHFFFAOYSA-N
Canonical SMILES CCOC(=O)Nc1ccc(cc1NC(=O)OC(C)(C)C)N(Cc1ccc(cc1)F)CC#C
Isomeric SMILES CCOC(=O)NC1=C(C=C(C=C1)N(CC#C)CC2=CC=C(C=C2)F)NC(=O)OC(C)(C)C
PubChem CID 155567226

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

References

1. Wang L, Qiao GH, Hu HN, Gao ZB, Nan FJ.  (2019)  Discovery of Novel Retigabine Derivatives as Potent KCNQ4 and KCNQ5 Channel Agonists with Improved Specificity..  ACS Med Chem Lett,  10  (1): (27-33).  [PMID:30655942]

Solution Calculators